Recent Securities Litigations

Silverback Therapeutics Inc. Common Stock (NASDAQ: SBTX)

35 Days left to seek lead plaintiff status.

Company Name:Silverback Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: SBTX
Class Period Start:12/03/2020
Class Period End (inclusive):09/10/2021
Filing Deadline:01/04/2022

The Complaint alleges that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, the Complaint alleges Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the Complaint alleges the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that: (i) Silverback's lead product candidate SBT6050 was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Silverback Therapeutics Inc. Common Stock (NASDAQ: SBTX) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.